000 01543 a2200433 4500
005 20250517210012.0
264 0 _c20190513
008 201905s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/s41375-018-0050-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThan, Hein
245 0 0 _aOngoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.
_h[electronic resource]
260 _bLeukemia
_c09 2018
300 _a2049-2054 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers, Tumor
650 0 4 _aClonal Evolution
_xgenetics
650 0 4 _aDNA Methylation
_xdrug effects
650 0 4 _aDecitabine
_xpharmacology
650 0 4 _aGenetic Heterogeneity
650 0 4 _aGenome-Wide Association Study
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelomonocytic, Chronic
_xdrug therapy
650 0 4 _aModels, Biological
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aExome Sequencing
700 1 _aQiao, Yi
700 1 _aHuang, Xiaomeng
700 1 _aYan, Dongqing
700 1 _aKhorashad, Jamshid S
700 1 _aPomicter, Anthony D
700 1 _aKovacsovics, Tibor J
700 1 _aMarth, Gabor T
700 1 _aO'Hare, Thomas
700 1 _aDeininger, Michael W
773 0 _tLeukemia
_gvol. 32
_gno. 9
_gp. 2049-2054
856 4 0 _uhttps://doi.org/10.1038/s41375-018-0050-z
_zAvailable from publisher's website
999 _c28225214
_d28225214